Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/10/09 → 07/8/10 |
Funding
- Quintiles Incorporated: $3,000.00
Solvay Pharma: A Double-Blind, Placebo-Controlled, Randomized, Multi-Center, Dose-Finding Study of SLV320, a Selective A1 Adenosine Receptor Antagonist, to Evaluate the Effect on Renal Function and Safety in Subjects Hospitalized.....
- Skopicki, Hal (PI)
- Mani, Anil (CoPI)
Project: Research